Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Relling

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Human Molecular Genetics|June 1, 1994
Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotypeR Saxena, G L Shaw, M V Relling, et al.
Clinical Pharmacology and Therapeutics|May 3, 2014
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotypeM V Relling, E M McDonagh, T Chang, et al.
Molecular Pharmacology|January 5, 2000
Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genesE G Schuetz, D R Umbenhauer, K Yasuda, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemiaW E Evans, J H Rodman, M V Relling, et al.
Journal of Pharmaceutical Sciences|June 1, 1989
Hepatic drug clearance in children: studies with indocyanine green as a model substrateW E Evans, M V Relling, S de Graaf, et al.
Medical and Pediatric Oncology|January 1, 1991
Concept of maximum tolerated systemic exposure and its application to phase I-II studies of anticancer drugsW E Evans, J H Rodman, M V Relling, et al.
The Journal of Pediatrics|October 1, 1987
Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemiaM L Garré, M V Relling, D Kalwinsky, et al.
Blood|March 1, 1997
Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemiaC L Chen, Q Liu, C H Pui, et al.
American Journal of Medical Genetics. Supplement|January 1, 1990
Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndromeD K Kalwinsky, S C Raimondi, N J Bunin, et al.
The Journal of Clinical Investigation|January 1, 1996
Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexateE Masson, M V Relling, T W Synold, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Human Molecular Genetics|June 1, 1994
Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotypeR Saxena, G L Shaw, M V Relling, et al.
Clinical Pharmacology and Therapeutics|May 3, 2014
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotypeM V Relling, E M McDonagh, T Chang, et al.
Molecular Pharmacology|January 5, 2000
Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genesE G Schuetz, D R Umbenhauer, K Yasuda, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemiaW E Evans, J H Rodman, M V Relling, et al.
Journal of Pharmaceutical Sciences|June 1, 1989
Hepatic drug clearance in children: studies with indocyanine green as a model substrateW E Evans, M V Relling, S de Graaf, et al.
Medical and Pediatric Oncology|January 1, 1991
Concept of maximum tolerated systemic exposure and its application to phase I-II studies of anticancer drugsW E Evans, J H Rodman, M V Relling, et al.
The Journal of Pediatrics|October 1, 1987
Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemiaM L Garré, M V Relling, D Kalwinsky, et al.
Blood|March 1, 1997
Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemiaC L Chen, Q Liu, C H Pui, et al.
American Journal of Medical Genetics. Supplement|January 1, 1990
Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndromeD K Kalwinsky, S C Raimondi, N J Bunin, et al.
The Journal of Clinical Investigation|January 1, 1996
Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexateE Masson, M V Relling, T W Synold, et al.
Pageof 18